Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
BioRestorative Therapies, Inc. (NASDAQ: BRTX)
BRTX Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
55.10%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
BRTX Stock Analysis
BRTX
PE Ratio:
BRTX
PEG Ratio:
Not Available
BRTX
Forward EPS Growth (12 month):
0.00%
BRTX
PS Ratio:
8.5
BRTX
PSG Ratio:
0.1
BRTX
Forward Revenue Growth (12 month):
64.60%
BRTX Articles
No data was found